What You’ll Learn:
- Innovation and Commercialization: Discover the latest innovations emerging from Toronto’s leading life sciences institutions and learn about how the commercialization process for life sciences innovations is being streamlined in the region.
- Supply and Demand: Discuss current dynamics and learn about how developers and investors are working to address the lack of supply in relation to demand.
- Funding and Investment: Gain insight into various funding sources, including venture capital, private equity, and government grants and if there will be a continued trend of large investment after AstraZeneca’s C$820M investment into Canada. Learn about the current trends in life sciences investment in Toronto.
- Sustainability and Resilience: Learn about sustainable practices in biotechnology and pharmaceutical research, and discover how these practices can enhance long-term viability and marketability.
- Collaborative Efforts: Dive into the impact of partnerships between academia, healthcare and industry on advancing life sciences.
- Support Systems: Learn about the role of incubators, accelerators and funding opportunities in nurturing life sciences startups.
Why You Should Attend:
Toronto is rapidly emerging as a global hub for life sciences, driven by significant investments, innovative research and a vibrant ecosystem that supports commercialization and growth. Understanding the latest trends, regulatory changes and investment opportunities is crucial for stakeholders looking to make a meaningful impact in this dynamic sector. Investors will gain critical insights and build valuable connections that can enhance the ability to navigate the complexities of life sciences development, financing and sustainability in Toronto. Through the knowledge and relationships gained at the event, investors can ensure their projects are both innovative and compliant.
Who You Will Meet:
Engage with stakeholders, including top researchers, industry leaders, researchers, industry leaders, investors, policymakers and representatives from government agencies who are at the forefront of Toronto’s life sciences sector.
